Search alternatives:
significant benefits » significant effects (Expand Search)
marked decrease » marked increase (Expand Search)
Showing 1 - 15 results of 15 for search '(( significantly ((marked decrease) OR (mean decrease)) ) OR ( significant benefits decrease ))~', query time: 0.45s Refine Results
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5

    Table 1_The impact of diagnosis-related group-based medical insurance payment model on the prognosis and nursing care of patients undergoing composite trabeculectomy: a retrospecti... by Yu Wang (12152)

    Published 2025
    “…Furthermore, the reform was associated with a marked decrease in hospitalization expenses and nursing costs. …”
  6. 6

    Image 4_Plasma cell targeting with the anti-CD38 antibody daratumumab in myalgic encephalomyelitis/chronic fatigue syndrome—a clinical pilot study.tiff by Øystein Fluge (200378)

    Published 2025
    “…Four patients had no significant clinical changes. Six patients experienced marked improvement. …”
  7. 7
  8. 8

    Data Sheet 1_Plasma cell targeting with the anti-CD38 antibody daratumumab in myalgic encephalomyelitis/chronic fatigue syndrome—a clinical pilot study.pdf by Øystein Fluge (200378)

    Published 2025
    “…Four patients had no significant clinical changes. Six patients experienced marked improvement. …”
  9. 9

    Image 2_Plasma cell targeting with the anti-CD38 antibody daratumumab in myalgic encephalomyelitis/chronic fatigue syndrome—a clinical pilot study.tiff by Øystein Fluge (200378)

    Published 2025
    “…Four patients had no significant clinical changes. Six patients experienced marked improvement. …”
  10. 10

    Image 3_Plasma cell targeting with the anti-CD38 antibody daratumumab in myalgic encephalomyelitis/chronic fatigue syndrome—a clinical pilot study.tiff by Øystein Fluge (200378)

    Published 2025
    “…Four patients had no significant clinical changes. Six patients experienced marked improvement. …”
  11. 11

    Table 1_Plasma cell targeting with the anti-CD38 antibody daratumumab in myalgic encephalomyelitis/chronic fatigue syndrome—a clinical pilot study.xlsx by Øystein Fluge (200378)

    Published 2025
    “…Four patients had no significant clinical changes. Six patients experienced marked improvement. …”
  12. 12

    Image 1_Plasma cell targeting with the anti-CD38 antibody daratumumab in myalgic encephalomyelitis/chronic fatigue syndrome—a clinical pilot study.tiff by Øystein Fluge (200378)

    Published 2025
    “…Four patients had no significant clinical changes. Six patients experienced marked improvement. …”
  13. 13

    Supplementary file 1_Therapeutic efficacy and safety of Xuebijing in traumatic brain injury: systematic review and meta-analysis.docx by Yihan Sun (3432287)

    Published 2025
    “…XBJ also markedly decreased systemic inflammatory biomarkers, including C-reactive protein (CRP; SMD = −1.34), tumour necrosis factor-alpha (TNF-α; SMD = −0.98), and interleukin-6 (IL-6; SMD = −0.98) (all p < 0.01). …”
  14. 14

    Data Sheet 1_Exploring long COVID in pediatric patients: clinical insights from a long COVID clinic.docx by Dina Kamel (22434430)

    Published 2025
    “…Overall symptom burden decreased significantly over time (p < 0.001). Vaccination status at baseline was not associated with difference in symptom duration on initial presentation (p = 0.4). …”
  15. 15

    Optimisation of read depth, DNA quantity, and unique alternate observation threshold. by Melinda L. Tursky (20790436)

    Published 2025
    “…J-L: Increasing unique alternative observation (UAO) thresholds for variant calls increased detection rate of rare variants (J), but markedly decreased the number of variants passing the threshold (K) and therefore reduced detection of true positive variants in reference standards (L). …”